Copyright
©The Author(s) 2021.
World J Clin Cases. Oct 16, 2021; 9(29): 8671-8693
Published online Oct 16, 2021. doi: 10.12998/wjcc.v9.i29.8671
Published online Oct 16, 2021. doi: 10.12998/wjcc.v9.i29.8671
Table 2 Baseline features of the colon adenocarcinoma patients in different risk groups, n (%)
| Features | TCGA-COAD cohort | GEO-GSE39582 cohort | ||||
| High-risk | Low-risk | P value | High-risk | Low-risk | P value | |
| Age | 0.795 | 0.862 | ||||
| < 65 yr | 70 (39.5) | 68 (38.2) | 105 (37.4) | 107 (38.1) | ||
| ≥ 65 yr | 107 (60.5) | 110 (61.8) | 176 (62.6) | 174 (61.9) | ||
| Sex | 0.265 | 0.351 | ||||
| Female | 86 (48.6) | 76 (42.7) | 132 (47.0) | 121 (43.1) | ||
| Male | 91 (51.4) | 102 (57.3) | 149 (53.0) | 160 (56.9) | ||
| TNM-stage | P < 0.001 | P = 0.002 | ||||
| I and II | 83 (46.9) | 114 (64.0) | 134 (47.7) | 170 (60.5) | ||
| III and IV | 89 (50.3) | 58 (32.6) | 145 (51.6) | 109 (38.8) | ||
| Unknown | 5 (2.8) | 6 (3.4) | 2 (0.7%) | 2 (0.7%) | ||
- Citation: Miao YD, Kou ZY, Wang JT, Mi DH. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma. World J Clin Cases 2021; 9(29): 8671-8693
- URL: https://www.wjgnet.com/2307-8960/full/v9/i29/8671.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i29.8671